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Background: Hematologic disease affects people of all ages worldwide. In the past decade, researchers have made
great progress in the field of hematology. In the present study we compared the hematology research output from
China and other countries (USA, Germany, UK, Japan and South Korea) over the past 10 years and 5 years.
Methods: The related articles were extracted based on the PubMed database. We recorded the number of publications,
clinical trials, randomized controlled trials, meta-analyses, case reports, reviews, citations, impact factors, articles in
the top 10 journals and most published journals to assess the quantity and quality of research output in each region.
Results: A total of 120,641 hematology-related articles were published from 2004 to 2013. The USA accounted for
27.13% (32,732/120,641) of the publications, followed by Germany (7,479/120,641; 6.20%), Japan (6,347/120,641; 5.26%),
the UK (5,453/120,641; 4.52%), China (2,924/120,641; 2.42%) and South Korea (1,413/120,641; 1.17%). The ranking for
cumulative impact factors was as follows: USA; Germany; UK; Japan; China and South Korea. The median impact factors
in the UK, USA, and Germany were higher than Japan, South Korea, and China. Interestingly, the median impact factors
in the three Asia countries were similar both in 2004–2013 and 2009–2013. The UK had the highest percentage of
publications in the top 25% of journals, while China lagged behind and ranked last. When comparing the number
of articles in the top 10 journals, the results were similar to the IF findings. Germany had the highest number of
average citations, while China had the lowest number of average citation. The status of hematology research output
from the 6 countries in 2009–2013 had little difference from 2004–2013.
Conclusions: Thus, the USA has had a dominant role in hematologic research in the past 10 years. Overall, the quality
of publications in European countries was better than Asia countries. Although China has made considerable progress
in hematology research, the quality of research needs improvement.
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Hematologic disease, including disorders of leukocytes,
erythrocytes, platelets, hemostatic mechanisms, vascular
biology, immunology, and hematologic oncology, affects
the health of people worldwide [1]. In the past decades,
the health status of the Chinese population has greatly
improved [2]; however, China still has a heavy burden of
hematologic disease according to the 2013 China Health* Correspondence: amdeng70@163.com; qianbh1963@163.com
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Health and Family Planning Commission of The People's
Republic of China [3].
Generally speaking, the number of published scientific
papers represents a country's scientific strength. Similarly,
the number of articles in a specific field also represents
the level of concern in the field. According to the Statis-
tical Data of Chinese S&T Papers 2013, which was re-
leased by the Chinese Institute of Scientific and Technical
Information, the number of Chinese scientific papers in
SCI ranked second amongst the top five countries; the
other four countries (in order) were the USA, Germany,
Japan, and the UK [4]. Currently, there are no dataThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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field of hematology. In the present study we determined
the contributions made by Chinese authors in the field of
hematology between 2004 and 2013. Due to the different
systems and funding mechanisms which exist in mainland
China, Hong Kong, and Taiwan, articles from Hong Kong
and Taiwan were not analyzed. Use of “China” herein re-
ferred to mainland China. The comparison of hematology
research output among China, the USA, UK, Germany,
Japan, and South Korea was not limited to 2004–2013,
but also included 2009–2013.
Results
Total number and share of articles
A total of 120,641 articles were published between 2004
and 2013 in the 68 hematology-related journals. TheFigure 1 The number (A) and share (B) of articles published in hematUSA accounted for the largest proportion (32,732/
120,641 [27.13%]), followed by Germany (7,479/120,641
[6.20%]), Japan (6,347/120,641 [5.26%]), the UK (5,453/
120,641 [4.52%]), China (2,924/120,641 [2.42%]) and
South Korea (1,413/120,641 [1.17%]). The changes in the
annual number and share of articles from each country
are shown in Figure 1. As shown in Figure 1, the num-
ber of papers published from China surpassed the num-
ber of papers published from UK in 2013 for the first
time, and approached the number of papers published
from Japan.
Clinical trials, randomized controlled trials, case reports,
meta-analyses, and reviews
The number of different types of articles from the six
countries is shown in Figure 2. USA ranked first in theology journals from the six countries (2004–2013).
Figure 2 The number of articles of different publication types from the six countries between 2004 and 2013.
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of meta-analyses published by China ranked second,
followed closely by the USA; other types of publications
from China just exceeded the number published from
South Korea.
Impact factor
Based on JCR 2014, we calculated the cumulative and
median IFs for each geographic region, which are shown
in Table 1. The ranking of the cumulative IFs in six
countries was the USA, Germany, the UK, Japan, China
and South Korea. The UK, USA, and Germany ranked
in the top three of median IFs, and the median IFs were
equal in the three Asia countries; these rankings did not
change in the past 5 or 10 years.
Furthermore, according to the IF, we divided the 68
journals into 4 levels. The number and percentage of
publications from each region in the four levels is shown
in Tables 2 and 3. From 2004 to 2013 [Table 2], The UKTable 1 Cumulative and median impact factor of articles from
Year Cumulative impact factors
China USA UK Germany Japan
2004 344.604 15393.468 2515.639 3332.788 2957.428
2005 387.774 15748.680 2527.391 3869.547 2909.071
2006 542.250 15728.758 2337.716 3430.667 2705.429
2007 745.716 16976.891 2777.760 4017.565 2637.568
2008 872.829 18383.301 2516.288 3528.121 2445.896
2009 1008.688 18934.461 2272.255 3663.200 2299.502
2010 1212.098 18158.917 2637.687 3488.621 2209.841
2011 1398.403 19753.856 2685.009 3638.619 2180.398
2012 1738.380 18695.207 2454.146 3492.870 2082.804
2013 1822.023 14523.517 2395.126 3468.483 2048.689
Total(2009–2013) 7179.592 90065.958 12444.223 17751.793 10821.234
Total(2004–2013) 10072.765 172297.056 25119.017 35930.481 24476.626ranked first, while China ranked last with respect to the
number of publications in the top 25% of journals (high-
est level). The same result was demonstrated in the
period between 2009 and 2013 [Table 3]. The distribu-
tion of publications from each country in the four grades
differed little between 2004–2013 and 2009–2013.
Citation reports
The rank of total citations-to-published articles between
2004 and 2013 was as follows: USA (921,553 citations
and 93,548 articles); Germany (260,570 citations and
23,970 articles); UK (158,171 citations and 19,393 arti-
cles); Japan (120,431 citations and 13,984 articles); China
(37,712 citations and 6,666 articles) and South Korea
(24,134 citations and 3,694 articles) [Figure 3]. Germany
had the highest average citations, meanwhile China had
the lowest average citations. It is noteworthy that the
average number of citations in Japan surpassed UK and
was much higher than South Korea and China [Table 4].each region
Median impact factors
South Korea China USA UK Germany Japan South Korea
288.41 2.692 4.202 4.304 3.568 2.806 3.326
415.235 2.692 4.304 4.959 4.421 3.348 2.732
450.98 2.692 4.202 4.304 3.693 2.732 2.692
457.462 2.692 4.304 4.304 4.304 2.732 3.348
460.531 2.732 4.202 4.202 3.466 2.692 2.659
601.775 2.605 4.304 4.053 3.568 2.692 2.916
566.511 2.605 3.693 4.959 3.466 2.562 2.562
619.563 2.692 4.202 4.304 3.568 2.627 2.627
539.097 2.605 3.568 4.304 3.466 2.562 2.562
662.632 2.627 3.568 4.959 3.477 2.462 2.468
2989.578 2.605 4.053 4.959 3.477 2.605 2.605
5062.196 2.692 4.053 4.538 3.568 2.692 2.692
Table 2 Distribution of publications from each region in the four grades (2004–2013)
Rank IF range China (%) USA (%) UK (%) Germany (%) Japan (%) South Korea (%)
Top 25% 11.089-4.046 809(27.67) 16901(51.63) 2973(54.52) 3583(47.91) 2170(34.19) 426(30.15)
Top 25%-50% 3.693-2.462 942(32.22) 10815(33.04) 1383(25.36) 1951(26.09) 1486(23.41) 415(29.37)
Bottom25%-50% 2.427-1.679 770(26.33) 3204(9.79) 598(10.97) 1310(17.52) 1726(27.19) 376(26.61)
Bottom 25% 1.590-0.101 403(13.78) 1812(5.54) 499(9.15) 635(8.49) 965(15.20) 196(13.87)
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The number of articles from each country of the jour-
nals which ranked in the top 10 according to the JCR
2014 is shown in Tables 5 and 6. The Blood Review is a
review journal and was not included in the top10. A
total of 23,153 articles were published in the top 10 jour-
nals by the 6 counties between 2004 and 2013 [Table 5].
Among the 6 countries, USA accounted for the over-
whelming majority of the number of articles (14,507/
23,153 [62.66%]), while the number of articles contrib-
uted by South Korea authors was relatively small (303/
23,153 [1.31%]). The number of articles published by
Chinese authors was also small (544/23,153 [2.35%]).
When comparing the data from 2009–2013 [Table 6],
the percentage of articles in the top 10 journals from
UK, Germany, and Japan decreased slightly, while the
percentage of articles in the top 10 journals from China,
USA, and South Korea had a small rise; all of these
changes were no more than 2 percentage points.Most published journals
The journals in which articles from the six countries were
published most frequently are listed in Tables 7 and 8. It is
worth noting that the same journal (Blood) was the most
frequent target journal in the USA and Germany; Blood
is one of the most influential journals in the field of
hematology.
Articles from China were most often published in
Leukemia Research, while the International Journal of
hematology and annals of hematology were the most
published journals in Japan and South Korea, respect-
ively. These three journals were not amongst the top 10
journals [Tables 7 and 8]. When comparing the results
between 2004–2013 and 2009–2013, there was no sig-
nificant difference.Table 3 Distribution of publications from each region in the f
Rank IF range China (%) USA (%)
Top 25% 11.089-4.046 579(27.07) 8705(50.56)
Top 25%-50% 3.693-2.462 669(31.28) 5662(32.89)
Bottom25%-50% 2.427-1.679 575(26.88) 1890(10.98)
Bottom 25% 1.590-0.101 316(14.77) 959(5.57)Discussion
This is the first study that compared the quantity and
quality of publications in hematology-related journals
from China and the USA, UK, Germany, Japan, and South
Korea. Publications from the six countries were extracted
based on the PubMed database, a free search engine pri-
marily accessing the MEDLINE database of references and
abstracts pertaining to the life sciences and biomedical
topics. The PubMed database was created by the United
States National Library of Medicine (NLM) at the
National Institutes of Health. The IF of each journal was
calculated using the JCR 2014, which helps to quantify the
influence of research and impact on the journal or cat-
egory levels; the IF also indicates the relationship between
citing and cited journals.
As shown in Figure 1, only China and South Korea ex-
hibited a sustained trend in growth between 2004 and
2013 with respect to the number of publications in
hematology-related journals. The USA had an upward
trend in the number of hematology articles published be-
tween 2004 and 2011, but the trend was reversed in the
last 3 years. The number of articles from the other three
countries (the UK, Japan, and Germany) remained rela-
tively stable. In 2013, China surpassed the UK and
approached Japan with respect to the number of
hematology articles published. There is no doubt that the
USA is the leader in this area of research and has a much
stronger research effort than the other five countries. The
same pattern was demonstrated when the publication of
different types of articles was analyzed. The USA was the
leader in publishing each type of article, especially reviews
and RCTs. A review is an attempt to summarize the
current state of understanding on a specific topic and
make comments, and is usually written by a leading expert
in the area [5]. A RCT is the gold standard for a clinical
trial, and is often used to determine the effectiveness ofour grades (2009–2013)
UK (%) Germany (%) Japan (%) South Korea (%)
1468(54.29) 1740(45.85) 922(31.50) 250(28.51)
659(24.37) 958(25.24) 637(21.76) 246(28.05)
358(13.24) 782(20.61) 902(30.82) 259(29.53)
219(8.10) 315(8.30) 466(15.92) 122(13.91)
Figure 3 Total number of citations of articles from each region
published in hematology journals between 2004 and 2013.
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vide information about adverse effects, such as drug reac-
tions. A RCT is considered to be the most reliable form of
scientific evidence in the hierarchy of evidence, and influ-
ences healthcare policy and practice. The results herein
demonstrated that the USA has made the greatest contri-
bution in the field of hematology. Specially, the number of
meta-analyses published from China approached the
number of meta-analyses published from the USA, which
can be explained by the rapid development of evidence-
based medicine in China.
With respect to the number of articles, China has
made tremendous progress. The GDP of China ranks
second in the world behind the USA. Between 2000 and
2012, the amount of research spent in China increased
from $10.8 billion to $168 billion. According to an
OECD estimation, the Chinese government invested
1.98% of the GDP in research in 2012 [6], and the
amount announced by the government may reach 2.5%Table 4 Total citations and average citations in the six countr
Citations China USA UK
6666articles 93548articles 19393artic
2004 46 3085 642
2005 362 18571 4023
2006 900 39048 8372
2007 1601 61372 13263
2008 2415 82679 18214
2009 3375 103407 23123
2010 4665 127350 22889
2011 6151 147856 21966
2012 8105 163462 21297
2013 10092 174723 24382
Total 37712 921553 158171
Average 5.657 9.851 8.156in 2020 [7]. Various types of medical research-funded
projects also increased considerably in the past decade.
For example, the Department of Health Sciences affili-
ated with the National Natural Science Foundation of
China was founded in 2009 and there is a special office
dedicated to funding respiratory, hematology, and circu-
latory system research. In fact, funds from this office in-
creased significantly from 228.81 million yuan in 2010 to
591.09 million yuan in 2013. Furthermore over the past
decade, the number of Chinese scientific and technical
personnel experienced the same rapid growth. All of
those factors have greatly promoted Chinese research in
the field of hematology.
The IF of an academic journal is a measure reflecting
the average number of citations to recent articles pub-
lished in the journal. The IF is frequently used as a
proxy for the relative importance of a journal within its
field; journals with higher IFs are deemed to be more
important than journals with lower IFs. Despite consid-
erable criticism regarding the IF, the IF is universally
accepted as the most convincing index for quality evalu-
ation of journals [8,9]. In the past 10 years, the cumula-
tive IFs of articles published in the USA were several
times higher than the other countries. With respect to
the median IF of published articles, the UK led the
countries surveyed, while the articles published from
Japan, China, and South Korea were significantly lower
than articles published from Europe and USA; these
findings did not change significantly in 2009–2013.
When comparing the distribution of publications related
to the IF, articles published from Europe and USA were
shown to be mostly published in the top 25% of journals;
however, China lagged behind and ranked last with
respect to publications in the top 25% of journals. This
is an important method regarding the evaluation ofies from 2004 to 2013
Germany Japan South Korea













Table 5 Number of publications in the top 10 hematology journals from each region (2004–2013)
Rank Journal 2013IF China (%) USA (%) UK (%) Germany (%) Japan (%) South Korea (%) Total
1 Circulation Research 11.089 44(1.90) 1725(74.68) 110(4.76) 263(11.39) 143(6.19) 25(1.08) 2310
2 Blood 9.775 127(1.49) 6342(74.59) 499(5.87) 964(11.34) 508(5.97) 63(0.74) 8503
3 Leukemia 9.379 45(3.46) 673(51.81) 142(10.93) 303(23.33) 125(9.62) 11(0.85) 1299
4 Stem Cells 7.133 77(4.78) 980(60.79) 96(5.96) 158(9.80) 212(13.15) 89(5.52) 1612
5 Haematologica 5.868 36(4.34) 276(33.29) 161(19.42) 269(32.45) 74(8.93) 13(1.57) 829
6 Thrombosis and Haemostasis 5.76 49(3.92) 466(37.25) 163(13.03) 445(35.57) 115(9.19) 13(1.04) 1251
7 Journal of Thrombosis and
Haemostasis
5.55 29(1.93) 863(57.53) 341(22.73) 127(8.47) 130(8.67) 10(0.67) 1500
8 Arteriosclerosis, Thrombosis,
and Vascular Biology
5.533 72(3.15) 1433(62.77) 156(6.83) 254(11.13) 320(14.02) 48(2.10) 2283
9 Journal of Cerebral Blood
Flow and Metabolism
5.339 39(2.92) 850(63.67) 150(11.24) 157(11.76) 126(9.44) 13(0.97) 1335
10 British Journal of Haematology 4.959 26(1.17) 899(40.30) 845(37.88) 246(11.03) 197(8.83) 18(0.81) 2231
Total 544(2.35) 14507(62.66) 2663(11.50) 3186(13.76) 1950(8.42) 303(1.31) 23153
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entists in this regard. This phenomenon, at least in part,
may be a reflection of China, Japan, and South Korea be-
ing non-English speaking countries. Indeed, European and
USA researchers may not pay close attention to scientific
findings published in languages other than English.
Despite the rapid growth in the number of articles
from China, the quality was not satisfactory. This may
be associated with the current imperfect evaluation sys-
tem on research performance that exists in mainland
China [10,11], which enforced researchers to pay more
attention to quantity rather than quality. The citation re-
ports and the number of publications in the top 10 jour-
nals further support the above conclusions.
There were several limitations in the present study.
Even though the journal list was generated based on theTable 6 Number of publications in the top 10 hematology jou
Rank Journal 2013IF China (%) USA (%)
1 Circulation Research 11.089 38(3.45) 846(76.84)
2 Blood 9.775 78(1.72) 3424(75.42)
3 Leukemia 9.379 21(3.23) 359(55.23)
4 Stem Cells 7.133 56(7.38) 483(63.64)
5 Haematologica 5.868 16(3.49) 172(37.47)
6 Thrombosis and Haemostasis 5.76 30(5.18) 216(37.31)






9 Journal of Cerebral Blood
Flow and Metabolism
5.339 27(3.65) 440(59.46)
10 British Journal of Haematology 4.959 18(1.72) 444(42.41)
Total 360(3.08) 7518(64.25)hematology category in SCIE subject categories, there
may be excellent hematology journals that were not in-
cluded by SCIE. Second, the publication of some inter-
national collaborative studies may have only listed one
address for all authors. Therefore, when included in this
study, the contributions of other countries were ignored.
Third, there are some hematology-related articles pub-
lished in general medical journals, which likely affected
our results.
Conclusions
In conclusion, there is no doubt that the USA has played
the most important role in the field of hematology re-
search in the past decade. Overall, the quality of publica-
tions in European countries is better than Asian countries.
We are delighted to see that China is closing the gap withrnals from each region (2009–2013)
UK (%) Germany (%) Japan (%) South Korea (%) Total
31(2.82) 115(10.45) 60(5.45) 11(1.00) 1101
274(6.04) 494(10.88) 237(5.22) 33(0.73) 4540
69(10.62) 139(21.38) 57(8.77) 5(0.77) 650
40(5.27) 62(8.17) 71(9.35) 47(6.19) 759
102(22.22) 140(30.50) 24(5.23) 5(1.09) 459
85(14.68) 190(32.82) 47(8.12) 11(1.90) 579
168(24.28) 69(9.97) 52(7.51) 9(1.30) 692
65(5.73) 110(9.69) 115(10.13) 29(2.56) 1135
95(12.84) 100(13.51) 70(9.46) 8(1.08) 740
397(37.92) 109(10.41) 72(6.88) 7(0.67) 1047
1326(11.33) 1528(13.06) 805(6.88) 165(1.41) 11702
Table 7 Ten most published hematology journals in each region (2004–2013)
Rank China N USA N UK N Germany N Japan N South Korea N
1 LR 214 Blood 6342 BJH 845 Blood 964 IJH 1020 AH 114
2 LL 188 CR 1725 Blood 499 TH 445 Blood 508 SC 89
3 IJH 168 PBC 1678 JTH 341 Leukemia 303 TAD 445 SCD 79
4 TR 141 ATVB 1433 Haemophilia 189 AH 299 ATVB 320 IJH 78
5 SCD 133 Transfusion 1351 VS 188 CHM 272 LR 235 Acta Heamatol 73
6 Blood 127 BBMT 1173 TH 163 Haematologica 269 TR 219 BMT 67
7 Shock 119 JLB 1048 Haematologica 161 CR 263 SC 212 LR 63
8 Cytotherapy 111 LL 1028 ATVB 156 Transfusion 255 BJH 197 Blood 63
9 AH 106 SC 980 JCBFM 150 ATVB 254 BMT 195 LL 56
10 JHO 79 AJH 899 LL 149 BJH 246 EJH 182 TR 53
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scientists from mainland China should take effective mea-
sures and strive to improve the quality of research.
Methods
Search strategy
Sixty-eight hematology journals were selected from the
Hematology category of the Science Citation Index
Expanded (SCIE) subject categories, as designated by
Thomson Reuters. The 68 journals, which are all
indexed by PubMed, cover resources that involve blood
and blood-forming tissues, as well as the function, dis-
eases, and treatments of the hematologic system. The
topics included hemophilia, neoplastic disorders of the
blood or lymphoid tissues, and mechanisms and disor-
ders of thrombosis. A computerized literature search
was conducted in the PubMed database on 2 October
2014, and the articles published in the 68 journals from
China, the USA, the UK, Germany, Japan, and SouthTable 8 Ten most published hematology journals in each reg
Rank China N USA N UK N
1 LR 152 Blood 3424 BJH 3
2 LL 143 PBC 1006 Blood 2
3 IJH 123 CR 846 JTH 1
4 TR 112 ATVB 759 Haematologica 1
5 SCD 108 BBMT 710 Haemophilia 1
6 AH 89 Transfusion 709 JCBFM 9
7 Shock 80 LL 573 TH 8
8 Blood 78 AJH 492 AJH 7
9 JHO 78 SC 483 Leukemia 6
10 Cytoherapy 75 BJH 444 Transfusion 6
Acta Haematol, IF = 0.994; AJH, Am J Hematol, IF = 3.477; AH, Ann Hematol, IF = 2.396; A
IF = 3.348; Blood, IF = 9.775; BP, Blood Purif, IF = 1.92; BMT, Bone Marrow Transplant, IF =
CHM, Clin Hemorheol Micro, IF = 2.215; EJH, Eur J Haematol, IF = 2.414; Haematologica, I
Hematol, IF = 1.87; JCBFM, J Cerebr Blood F Met, IF = 5.339; JHO, J Hematol Oncol, IF = 4.
J Thromb Haemost, IF = 5.55; Leukemia, IF = 9.379; LL, Leuk Lymphoma, IF = 2.605; LR, Le
Cells, IF = 7.133; SCD, Stem Cells Dev, IF = 4.202; TAD, Ther Apher Dial, IF = 1.532; TH, Thr
IF = 2.427; Transfusion, IF = 3.568; VS, Vox Sang, IF = 3.303.Korea between 1 January 2004 and 31 December 2013
were identified.
The ISSN (print) and publication date (print) were
used to perform searches in the PubMed database. The
search terms were “China[ad] not Hongkong[ad] not
Taiwan[ad]”, “USA[ad]”, “UK[ad]”, “Germany[ad]”,
“Japan[ad]”, “Korea[ad]” and “0001-5792 OR 0361–8609
OR 0939–5555 OR 1079–5642 OR 1521–6926 OR
1083–8791 OR 0006-355X OR 0006–4971 OR 1079–
9796 OR 0957–5235 OR 0253–5068 OR 0268-960X OR
1723–2007 OR 0268–3369 OR 0007–1048 OR 0009–
7330 OR 1076–0296 OR 1386–0291 OR 2152–2650 OR
1040–8428 OR 1558–8211 OR 1065–6251 OR 1465–
3249 OR 0902–4441 OR 0301-472X OR 1747–4086 OR
0234–5730 OR 0390–6078 OR 1351–8216 OR 0720–
9355 OR 0278–0232 OR 1024–5332 OR 1520–4391 OR
0889–8588 OR 0363–0269 OR 0971–4502 OR 0925–
5710 OR 1751–5521 OR 0271-678X OR 0733–2459 OR
1756–8722 OR 0741–5400 OR 1077–4114 OR 1538–ion (2009–2013)
Germany N Japan N South Korea N
97 Blood 494 IJH 547 AH 82
74 CHM 197 Blood 237 SCD 58
68 TH 190 TAD 201 IJH 51
02 AH 144 TR 120 SC 47
00 Haematologica 140 ATVB 115 LR 43
5 Leukemia 139 LR 109 Acta Haematol 42
5 TMH 136 BMT 92 Blood 33
3 CR 115 EJH 74 TR 33
9 Transfusion 113 BJH 72 IJLH 32
8 ATVB 110 SC 71 ATVB 29
TVB, ArteriosclerThrombVasc Biol, IF = 5.533; BBMT, Biol Blood Marrow Transplant,
3.466; BJH, Br J Haematol, IF = 4.959; CR, Circ Res, IF = 11.089; Cytotherapy, IF = 3.1;
F = 5.868; Haemophilia, IF = 2.468; IJH, Int J Hematol, IF = 1.679; IJLH, Int J Lab
933; JLB, J Leukoc Biol, IF = 4.304; JPHO, J Pediatr Hematol Oncol, IF = 0.956; JTH,
uk Res, IF = 2.692; PBC, Pediatr Blood Cancer, IF = 2.562; Shock, IF = 2.732; SC, Stem
omb Haemost, IF = 5.76; TMH, Transfus Med Hemoth, IF = 2.011; TR, Thromb Res,
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0145–2126 OR 1073–9688 OR 1545–5009 OR 0888–
0018 OR 0953–7104 OR 0037–1963 OR 0094–6176 OR
1073–2322 OR 1066–5099 OR 1547–3287 OR 1744–
9979 OR 0340–6245 OR 0049–3848 OR 0041–1132 OR
1473–0502 OR 1246–7820 OR 1660–3796 OR 0958–
7578 OR 0887–7963 OR 1300–7777 OR 0042–9007.”
Articles in which the first author was affiliated with the
above geographic regions were considered to be research
output from the respective region. According to the
publication types in PubMed, the number of clinical tri-
als, randomized controlled trials (RCTs), meta-analyses,
and reviews from each geographic region were extracted.
We used three methods to assess the quality of the lit-
erature. First, the cumulative impact factors (IFs) and
the median IF were calculated using Journal Citation
Reports (JCR) 2014, which is published by Thomson
Reuters, and the article distribution related to IFs was
also assessed for each region. Second, citation reports of
articles showing an affiliation with each region were col-
lected using the Web of Science. Third, articles pub-
lished in the top 10 hematology journals (based on IFs)
were counted, while the 10 most published hematology
journals in each region, according to the publication
number, were also identified. The above comparisons
were also conducted based on the data from 2009–2013
(Additional file 1).
Statistical analysis
We focused on the trends and not to test the hypothesis
regarding the relative contributions of each region.
Therefore, only simple descriptive statistics (e.g., sum
and median) are provided in this study.
Additional file
Additional file 1: The main flowchart of the study.
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